C-reactive protein, lipid-soluble micronutrients, and survival in colorectal cancer patients

Cancer Epidemiology Biomarkers and Prevention

Volumn 22, Issue 7, 2013, Pages 1278-1288

  Cooney, Robert V ^a   Chai, Weiwen ^b   Franke, Adrian A ^b   Wilkens, Lynne R ^b   Kolonel, Laurence N ^a,b   Le Marchand, Loïc ^b  

^a UNIVERSITY OF HAWAII   (United States)

^b UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CAROTENE; ALPHA TOCOPHEROL; BETA CRYPTOXANTHIN; C REACTIVE PROTEIN; CAROTENOID; GAMMA TOCOPHEROL; LYCOPENE; RETINOL; TOCOPHEROL; TRACE ELEMENT; UBIDECARENONE; XANTHOPHYLL; ZEAXANTHIN;

ADULT; ARTICLE; CANCER PATIENT; COLORECTAL CANCER; ETHNICITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PHLEBOTOMY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SEX; SMOKING; SURVIVAL;

AGED; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; HAWAII; HUMANS; MALE; MICRONUTRIENTS; MIDDLE AGED; SEER PROGRAM; SURVIVAL ANALYSIS; VITAMIN D;

EID: 84880013951     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-13-0199     Document Type: Article

References (53)

1. Kim YS, Milner JA. Dietary modulation of colon cancer risk. J Nutr 2007;137:2576S-9S. (Pubitemid 350058739)
2. Terzić J, Grivennikov S, Karin E, Karin M. Inflammation and colon cancer. Gastroenterology 2010;138:2101-14.
3. Brenner H, Hakulinen T. Up-to-date estimates of cancer patient survival even with common latency in cancer registration. Cancer Epidemiol Biomarkers Prev 2006;15:1727-32. (Pubitemid 44497110)
4. Viennot S, Deleporte A, Moussata D, Nancey S, Flourie B, Reimund JM. Colon cancer in in flammatory bowel disease: recent trends, questions and answers. Gastroenterol Clin Biol 2009;33(Suppl3):S190-S201.
5. Pepys MB, Hirschfield GM, C-reactive protein: a critical update. J Clin Invest 2003;111:1805-12. (Pubitemid 38057722)
6. Din FV, Theodoratou E, Farrington SM, Tenesa A, Barnetson RA, Cetnarskyj R, et al. Effect of aspirin and NSAIDs on risk and survival from colorectal cancer. Gut 2010;59:1670-9.
7. Chandra RK. Nutrition, immunity and infection: from basic knowledge of dietary manipulation of immuneresponses to practical application of ameliorating suffering and improving survival. Proc Natl Acad Sci USA 1996;93:14304-7. (Pubitemid 26418958)
8. Moghaddam AA, Woodward M, Huxley R. Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol Biomarkers Prev 2007;16:2533-47. (Pubitemid 351196307)
9. Willett WC. Diet and cancer: one view at the start of the millennium. Cancer Epidemiol Biomarkers Prev 2001;10:3-8. (Pubitemid 32106038)
10. Koushik A, Hunter DJ, Spiegelman D, Beeson WL, van den Brandt PA, Buring JE, et al. Fruit, vegetables, and colon cancer risk in a pooled analysis of 14 cohort studies. J Natl Cancer Inst 2007;99:1471-83.
11. Giovannuci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ, et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 2006;98:451-9.
12. Duthie SJ. Folate and cancer: how DNA damage, repair and methylation impact on colon carcinogenesis. J Inherit Metab Dis 2011;34:101-9.
13. Mason JB, Dickstein A, Jacques PF. A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis. Cancer Epidemiol Biomarkers Prev 2007;16:1325-9.
14. Garland C, Comstock G, Garland F, Helsing K, Shaw E, Gorham E. Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet 1989;2:1176-8. (Pubitemid 19275448)
15. Nikiteas NI, Tzanakis N, Gazouli M, Rallis G, Daniilidis K, Theodoropoulos G, et al. Serum IL-6, TNFa, and CRP levels in Greek colorectal cancer patients: prognostic implications. World J Gastroenterol 2005;11:1639-43. (Pubitemid 40520804)
16. Heikkila K, Ebrahim S, Rumley A, LoweG, Lawlor DA. Associations of circulating C-reactive protein and interleukin-6 with survival in women with and without cancer: findings from the British Women's Heart and Health Study. Cancer Epidemiol Biomarkers Prev 2007;16:1155-9. (Pubitemid 46984952)
17. Vrieling A, Kampman E. The role of body mass index, physical activity, and diet in colorectal cancer recurrence and survival: a review of the literature. Am J Clin Nutr 2010;92:471-90.
18. Heys SD, Walker LG, Deehan DJ, Eremin OE. Serum albumin: a prognostic indicator in patients with colorectal cancer. J R Coll Surg Edinb 1998;43:163-8. (Pubitemid 28306032)
19. Koike Y, Miki C, Okugawa Y, Yokoe T, Toiyama Y, Tanaka K, et al. Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer. J Surg Oncol 2008;98:540-4.
20. Phipps AI, Baron J, Newcomb PA. Prediagnostic smoking history, alcohol consumption, and colorectal cancer survival: the Seattle Colon Cancer Family Registry. Cancer 2011;117:4948-57.
21. Ng K, Wolpin BM, Meyerhardt JA, Wu K, Chan AT, Hollis BW, et al. Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer. Br J Cancer 2009;101:9916-23.
22. Formelli F, Meneghii E, Cavadini E. Plasma retinol and prognosis of postmenopausal breast cancer patients. Cancer Epidemiol Biomarkers Prev 2009;18:42-8.
23. Rock CL, Natarajan L, Pu M, Thomson CA, Flatt SW, Caan BJ, et al. Longitudinal biological exposure to carotenoids is associated with breast cancer-free survival in the Women's Healthy Eating and Living Study. Cancer Epidemiol Biomarkers Prev 2009;18:486-94.
24. Eicholzer M, Stahelin HB, Gey KF, L €udin E, Bernasconi F. Prediction of male cancer mortality by plasma levels of interacting vitamins: 17-year follow-up of the prospective Basel study. Int J Cancer 1996;66:145-50. (Pubitemid 26248191)
25. Wright ME, Lawson KA, Weinstein SJ, Pietinen P, Taylor PR, Virtamo J, et al. Higher baseline serum concentrations of vitamin E are associated with lower total and cause-specific mortality in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Clin Nutr 2006;84:1200-7. (Pubitemid 44730393)
26. Rusciani L, Proietti I, Rusciani A, Paradisi A, Sbordoni G, Alfano C, et al. Low plasma coenzyme Q10 levels as an independent prognostic factor for melanoma progression. J Am Acad Dermatol 2005;54:234-41. (Pubitemid 43144392)
27. 10 and other antioxidants: a pilot study. J Int Med Res 2009;37:1961-71.
28. Lloyd-Jones DM, Kiang L, Lu T, Greenland P. Narrative review: assessment of C-reactive protein in risk prediction for cardiovascular disease. Ann Intern Med 2006;145:35-42. (Pubitemid 46780605)
29. Ito Y, Suzuki K, Ishii J, Hishida H, Tamakoshi A, Hamajima N, Aoki K. A population-based follow-up study on mortality from cancer or cardiovascular disease and serum carotenoids, retinol and tocopherols in Japanese inhabitants. Asian Pacific J Cancer Prev 2006;7:533-46.
30. Moro JR, Iwata M, von Andriano UH. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol 2008;8:685-98.
31. Meydani SN, Tengerdy RP. Vitamin E and immune response. In:Packer L, Fuchs J editors. Vitamin E in health and disease New York, New York: Marcel-Dekker; 1993. p. 549-61.
32. Samuel S, Sitrin MD. Vitamin D's role in cell proliferation and differentiation. Nutr Rev 2008;66(10 Suppl 2):S116-24.
33. Le Marchand L, Wilkens LR, Hankin JH, Kolonel LN, Lyu LC. A case-control study of diet and colorectal cancer in a multiethnic population in Hawaii (United States): lipids and foods of animal origin. Cancer Causes Control 1997;8:637-48. (Pubitemid 27330497)
34. Le Marchand L, Wilkens LR, Kolonel LN, Hankin JH, Lyu LC. Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer. Cancer Res 1997;57:4787-94. (Pubitemid 27468985)
35. Franke AA, Custer LJ, Cooney RV. Synthetic carotenoids as internal standards for plasma micronutrient analysis by high-performance liquid chromatography. J Chromatogr B 1993;614:43-57. (Pubitemid 23122479)
36. NIST special publication #874 Methods for analysis of cancer chemopreventive agents in human serum. Washington, DC: Government Printing Office; 1994.
37. Franke AA, Murphy SP, Lacey R, Custer LJ. Tocopherol and tocotrienol levels of foods consumed in Hawaii. J Agric Food Chem 2007;55:769-78.
38. Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med 1989;8:551-61. (Pubitemid 19116001)
39. Li R HE, Louie M, Chen L, Spiegelman D. The SAS LGTPHCURV8 Macro, [cited 2006 Aug 9]. Available from: http://www.hsph.harvard.edu/faculty/spiegelman/ lgtphcurv8/lgtphcurv8.pdf.
40. Sobin LH, Wittekind C, editors. TNM classification of malignant tumors, 5th ed. New York, New York: Wiley-Liss; 1997.
41. Cooney RV, Franke AA, Hankin JH, Custer LJ, Wilkens LR, Harwood PJ, et al. Seasonal variations in plasma micronutrients and antioxidants. Cancer Epidemiol Biomarkers Prev 1995;4:207-15.
42. Erlinger TP, Platz EA, Rifai N, Helzlsouer KJ. C-reactive protein and the risk of incident colorectal cancer. JAMA 2004;291:585-90. (Pubitemid 38500312)
43. Laurent A, Nicco C, Chereau C, Goulvestre C, Alexandre J, Alves A, et al. Controlling tumor growth by modulating endogenous production of reactive oxygen species. Cancer Res 2005;65:948-56. (Pubitemid 40216456)
44. Bastiaannet E, Sampierii K, Dekkers OM, de Craen AJ, van Herk-Sukel MP, Lemmens V, et al. Use of aspirin postdiagnosis improves survival for colon cancer patients. Br J Cancer 2012;106:1564-70.
45. Wang XL, Rainwater DL, Mahaney MC, Mahaney MC, Stocker R. Co-supplementation with vitamin E and coenzyme Q10 reduces circulating markers of in flammation in baboons. Am J Clin Nutr 2004;80:649-55. (Pubitemid 41115530)
46. Shardell MD, Alley DE, Hicks GE, El-Kamary SS, Miller RR, Semba RD, et al. Low-serum carotenoid concentrations and carotenoid interactions predict mortality in U.S. adults: the Third National Health and Nutrition Examination Survey. Nutrition Res 2011;31:178-89.
47. Li C, Ford E, Zhao G, Balluz LS, Giles WH, Liu S. Serum α-carotene concentrations and risk of death among US adults. Arch Intern Med 2011;171:507-15.
48. Agudo A, Cabrera L, Amiano P, Ardanaz E, Barricarte A, Berenguer T, et al. Fruit and vegetable intakes, dietary antioxidant nutrients, and total mortality in Spanish adults: findings from Spanish cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Spain). Am J Clin Nutr 2007;85:1634-42. (Pubitemid 46890434)
49. Akbaraly T, Favier A, Berr C. Total plasma carotenoids and mortality in elderly: results of the Epidemiology of Vascular Ageing (EVA) study. Br J Nutr 2009;101:86-92. (Pubitemid 352795586)
50. Lauretani F, Semba R, Dayhoff-Brannigan M, Corsi AM, Di Iorio A, Buiatti E, et al. Low total plasma carotenoids are independent predictors of mortality among older persons in CHIANTI study. Eur J Nutr 2008;47:335-40.
51. Schottker B, Haug U, Schomburg L, Koehler J, Perna L, Muller H, et al. Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study. Am J Clin Nutr 2013;97:782-93.
52. Michaelsson K, Melhus H, Warensjö Lemming E, Wolk A, Byberg L. Long term calcium intake and rates of all cause and cardiovascular mortality: community based prospective longitudinal cohort study. BMJ 2013;346:f228.
53. Melichar B, Krcmova L, Kalabova K, Holeckova P, Kasparova M, Plisek J, et al. Serum retinol, alpha-tocopherol and systemic inflammatory response in metastatic colorectal carcinoma patients treated with combination chemotherapy and cetuximab. J Nutr Sci Vitaminol 2010;56:222-6.